Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Antifungal cyclohexapeptides from Merck & Co.

Sep. 20, 1996

Safe, broad-spectrum quinolones from Wakunaga

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

New quinolone from Bayer undergoing extensive evaluation

Sep. 20, 1996

Antiinfective drugs in development at Daiichi

Sep. 13, 1996

Antiinfective R&D at Toyama

Sep. 13, 1996

Antirhinovirus compounds from Lilly

Sep. 13, 1996

Antibacterial 2-pyridones, a novel class of DNA gyrase inhibitors

Sep. 13, 1996

Merck & Co. discloses novel antifungal agent

Sep. 13, 1996

Natural antibacterial agent reported by Korean researchers

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...